This inventor holds 1 USPTO granted patent. Top assignee: Eisai Company, Limited. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Norio Shibata: Innovator in Medicinal Chemistry
Introduction
Norio Shibata is a distinguished inventor based in Toyama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as potential treatments for various forms of dementia and attention deficit hyperactivity disorder.
Latest Patents
Shibata holds a patent for a novel compound known as 1-benzyl-4[(5,6-dimethoxy-2-fluoro-1-indanone)-2-yl]methylpiperidine. This compound is recognized for its utility as a medicament and an acetylcholinesterase inhibitor. It is specifically designed to prevent, treat, and improve conditions such as senile dementia, Alzheimer-type senile dementia, and cerebrovascular dementia.
Career Highlights
Throughout his career, Norio Shibata has been associated with Eisai Company, Limited, a prominent pharmaceutical company. His work has focused on innovative solutions in the realm of neuropharmacology, contributing to advancements in therapeutic options for cognitive disorders.
Collaborations
Shibata has collaborated with notable colleagues, including Emiko Suzuki and Takashi Kosasa. Their combined expertise has fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
Norio Shibata's contributions to medicinal chemistry and his innovative patent highlight his commitment to improving healthcare outcomes. His work continues to influence the development of treatments for cognitive disorders, showcasing the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile